This study has public registry information. It focuses on mental health and currently lists study information in Canada, Italy, the Netherlands, Spain, the United Kingdom, and the United States.
This study exists to better understand the safety of the medication Adjunctive and how manageable it feels in practice. For people living with Mental health, that matters because care needs to work in daily life, not just in theory. The findings could guide better understanding and future care, and taking part helps build that evidence for others.
The official record suggests in-person participation through a hospital, with sites including Metropolitan Neuro Behavioral Institute in Chandler, Alea Research in Phoenix, and NoeisisPharma, LLC in Phoenix. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually having a stable enough treatment background for the study and being able to follow the planned visits or tasks, while common reasons not to take part include safety concerns that need urgent care first and other treatments that could interfere with the study. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may help improve understanding of your condition.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in Canada.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with mental health. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Biohaven Pharmaceuticals, Inc.. Based on the sponsor name or official registry information, it appears to be another type of organization. You should verify the details in the official registry record.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.